Delivery Order SPE2DB22D3004-SPE2DB25FRU72
- Not listed
- The Defense Logistics Agency awarded a $3,649 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Gel-One 30 mg/3 mL syringes. This firm fixed-price delivery order is expected to be completed by August 12, 2025, and represents a non-competitive set-aside contract. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Gel-One 30 mg/3 mL syringes valued at $9,122.50 with completion scheduled for October 7, 2025. This firm fixed-price delivery order, performed at AmerisourceBergen's Conshohocken, Pennsylvania location, was competitively awarded without set-aside designation. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $4.38K to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 ml syringes on September 8, 2025, with completion expected by September 29, 2025. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion prime vendor agreement (SPE2DX) extending through December 2026. The contract employs firm fixed-price pricing and was competitively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $5,473.50. This firm fixed price delivery order, with an ultimate completion date of September 12, 2025, represents a competitive award with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $1,094.70. This is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a $7,298.00 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Gel-One 30 mg/3 mL syringes. This firm fixed-price contract, with an ultimate completion date of September 4, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. The contract was...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,298.00 by the Defense Logistics Agency (DLA) on September 12, 2025, for the supply of Gel-One 30 mg/3 mL syringes (3 mL quantity). The contract carries a firm fixed price structure with no set-aside designation and an ultimate completion date of October 3, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $1,459.60. This competitively awarded, firm fixed-price delivery order is classified as a child contract and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement. The product will be performed at the company's headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a $14,596 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Gel-One 30 mg/3 mL syringes. The contract, which is competitively awarded with no set-aside designation, carries a firm fixed price structure and an ultimate completion date of September 10, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Gel-One 30 mg/3 mL syringes (3 mL units) with a ceiling value of $18,245.00. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The product will be performed from the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. This delivery order is issued...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRU72Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Gel-One 30 mg/3 ml syringes with a ceiling value of $4,013.90. This is a firm fixed price delivery order with an ultimate completion date of August 25, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a substantial $1 billion prime contract vehicle that runs through December 2026 and serves as a comprehensive pharmaceutical supply solution for military and federal healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a critical role in the Defense Logistics Agency's medical supply chain. As a competitively awarded vendor, the company supplies a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other federal agencies. The delivery order for Gel-One syringes represents a routine pharmaceutical supply transaction consistent with the company's portfolio of federal contracts, which encompasses brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 8/4/25 |